ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,336, issued on Oct. 7, was assigned to Dicerna Pharmaceuticals Inc. (Lexington, Mass.).

"Compositions and methods for inhibiting LPA expression" was invented by Bob Dale Brown (Littleton, Mass.), Henryk T. Dudek (Belmont, Mass.), Marc Abrams (Natick, Mass.), Wen Han (Boston) and Anton Turanov (Revere, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Oligonucleotides are provided herein that inhibit apolipoprotein(a) (LPA) expression. Also provided are compositions including the same and uses thereof, particularly uses relating to treating diseases, disorders and/or conditions associated with LPA expression."

The patent was filed on Aug. 5, 2021,...